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Summary
Using the best animal models to study immune responses against specific pathogens or vaccines 
can dramatically accelerate our understanding. Veterinary species are well studied, particularly 
livestock, to reduce their disease burden. They have also proven to be powerful models, 
especially for zoonotic pathogens and novel vaccination strategies. A prerequisite for any model 
selection is having the right quality and range of species-specific immunological reagents. To help 
promote the widest possible use of veterinary species, an open access website 
(https://www.immunologicaltoolbox.co.uk) has been created as a central community annotated 
hub for veterinary immunological reagents. The website is also the portal into services offered by 
the UK Immunological Toolbox project that includes antibody generation, sequencing and 
recombinant expression.  The funding for this effort is linked into sustainable sources but ultimate 
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success still relies on community engagement to continually increase the quality and quantity of 
information. It is hoped that as more users and reagent owners engage it will become an 
essential resource for researchers, veterinarians and clinicians alike by removing barriers that 
prevent the use of the most informative animal models.
Keywords: Antibodies, comparative immunology, veterinary vaccinology, immunological reagents
Article
The potential of comparative immunology has never been greater. New high-throughput 
technologies are becoming increasingly adaptable across species, creating enormous 
opportunities to push the utility and applicability of comparative research. Zoonotic infections 
continue to emerge, and novel vaccine design and delivery challenges often require large scale 
development and testing in animal models1, 2. The continuous co-evolution of host-pathogen 
relationships has driven the complexity and diversity of the innate and adaptive immune systems 
between different species3. Several basic principles of immunobiology were established by 
exploiting opportunities that different animals offer. Sheep were used as an experimental system 
to study lymphocyte recirculation in studies initiated over 50 years ago. These studies made a 
seminal contribution to current immunotherapies involving adoptive transfer of T cells in humans 
4. B cell immunology originates from studies on the Bursa of Fabricius in chickens, a species that 
has also helped to establish the principles of MHC class I peptide selection and loading 5. Using 
the right animal models can dramatically improve the quality and relevance of the data to reduce 
th  development time of therapeutics. The pig is a natural mixing vessel of influenza viruses and 
is emerging as an important model for disease and vaccination6. Calves have proven essential to 
understand the mechanisms of immunity and pathogenesis of human and bovine respiratory 
syncytial virus, proving essential to evaluate human vaccine candidates7.  Many species, 
particularly dogs, have underpinned our fundamental understanding of oncogenesis, including 
virally induced cancers and subsequent vaccines and immunotherapies 8, 9. However, the power 
of any given model is dependent on the availability, and quality of the tools and reagents 
available10. 
Although there are commonalities in immune system structure and function, at the molecular level 
there is often low homology between orthologues across species, such as cytokine/cytokine 
receptor interactions11. Consequently, immunological reagents tend to exhibit low species cross-
reactivity, a feature that is often overlooked when moving from human and mouse studies into 
novel species. The immunological toolboxes for laboratory mice and humans are extensive but 
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cannot necessarily be applied to livestock, companion animals or wildlife species. For example, 
only 55 % of anti-human antibodies tested on pig blood cells gave consistent binding, with a 
subset showing novel cellular distribution compared to humans with clear gaps remaining in what 
are clearly fundamental immunological pathways 12, 13. This creates a barrier to understanding 
host-pathogen interactions in those species and identifying the mechanisms of protective 
immunity that can underpin strategic vaccine design. Improving the immunological toolbox across 
species will enable comparative immunological studies and expedite the development of 
strategies for disease control.
Until the late 1980’s, research in veterinary species was fundamental to our basic understanding 
of mammalian immune system function and development14. The technological landmark of 
monoclonal antibody production in the 1980s drove a massive acceleration in tools and 
technologies to investigate the immune system at ever finer resolution15. Murine immunology 
emerged and remains at the centre of fundamental discoveries that underpinned key 
immunological paradigms that still stand today. However, monoclonal antibody specificity often 
precludes reactivity with the equivalent protein orthologs in other species, and inevitably reagents 
for veterinary species lagged behind. The global effort to equip the veterinary immunological 
toolbox at the molecular level began in the 1980s with a notable drive to produce monoclonal 
antibodies that could identify lymphoid cell subsets. These efforts were largely focussed, but not 
exclusively, around livestock and poultry to help design and improve disease control measures in 
key food producing species16. 
The investment in veterinary antibodies has largely relied on limited-term funding opportunities, 
spread across different species, countries and often diverse disease problems. This inevitably 
creates challenges in the coordination and knowledge exchange of past and future efforts that 
short-term funding is unable to consolidate. The United Kingdom Research and Innovation - 
Biotechnology and Biological Sciences Research Council (UKRI-BBSRC) Veterinary Vaccinology 
Strategy 2015-2020 highlighted this funding issue alongside the acknowledgement that that there 
are generic vaccinology research gaps that would benefit from coordinated research efforts with 
immunology, technology and immunological reagents being the three main long-term research 
challenges globally and in the UK17.
The Pirbright Institute (TPI) and The Roslin Institute (TRI) are strategically funded UKRI-BBSRC 
Institutes with a remit to undertake and promote research driving improvements in farmed animal 
health and productivity. Both Institutes have a strong track record in developing veterinary 
immune reagents which placed them in an ideal position to link immunological toolbox activities 
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with their core strategic funding. This is a new funding model providing a greater level of financial 
sustainability that has led to the creation of the UK Immunological Toolbox project. Over the last 
two years TPI and TRI have coordinated and consolidated their veterinary toolbox activities and 
engaged as widely as possible with the research community on how to promote veterinary 
immunology research. 
A community-focussed reagent database and website portal with consolidated information was 
considered by far the most immediate need of the community. It was also recognised that 
community buy-in was key to make such a website accurate and current. To address this need 
the UK Immunological Toolbox website (https://www.immunologicaltoolbox.co.uk) was recently 
released and provides a manually curated and centralised resource of information on over 1600 
antibodies and recombinant proteins from nine species, including livestock, companion animals 
and fish. These reagents include those available from commercial companies, institutional 
collections and individual labs. We estimate that we describe over half of the characterised 
antibodies held by the community globally; with many more partners committed to providing 
reagent information soon.
The website has been designed to present basic information (clone name, isotype, target, cross-
reactivity, etc.) alongside as much evidence as possible that promotes their use, such as 
references, methods and images. This includes the capacity for registered users to ‘rate’ reagents 
based on their own experiences in different applications and to provide comments and supporting 
evidence in almost any format. All comments and information are linked to the registered users 
that submitted the data and passed to the curation team to ensure basic quality. This rating 
feature is intended to accelerate research by only sourcing and trialling antibodies that are likely 
to work in any particular application. As such, the reagent owner and/or supplier is prominently 
displayed alongside current availability. Where applicable, links to species specific websites and 
resources are provided allowing a greater level of detail to avoid duplication or wasted effort.
Research community engagement is equally as important as sustainable funding. Increasing the 
quality and volume of data will secure the future of this database and website. An international 
panel of volunteers with a research background for species have been identified to help promote 
the website and curate the information. The submission feature is located on the homepage and 
the form is designed to make it easy for users to submit new reagents or information on existing 
reagents with automated fields where possible. 
The current more secure funding allows planning for future developments. The underlying data 
structure and website is highly scalable and is already capable of hosting additional information 
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such as expression patterns, interacting partners, functions, isoforms, and epitopes. There is also 
the option for the cDNA and DNA information, from genome locations, SNPs, copy number 
variations, splice variants and PCR primers and probes, to be added in the future. 
The website also acts as the portal to access other initiatives and services offered through the UK 
Immunological Toolbox project through online submission. The development of new reagents can 
be suggested based on individual and community need and reviewed by an expert steering 
committee. We have also started a major project to sequence all hybridoma cells held at both TPI 
and TRI, as well as those from collaborating institutes around the world as requested. The 
primary driver is to secure these important reagents for the future, whilst also allowing us to share 
reagents at the level of sequence or construct; where available recombinant versions of 
antibodies are listed. When combined with our panel of vectors that enable expression of 
recombinant antibodies of multiple isotypes from mouse, cattle, pig and chicken, the utility of 
these veterinary antibodies is greatly increased. 
This capability helped attract The Livestock Antibody Hub (www.immunologicaltoolbox.co.uk/hub) 
to The Pirbright Institute, which is contributing to the capacity and capability to sequence single B 
cells from livestock species. In combination with the UK Immunological Toolbox expression 
system, this now allows the direct generation of monoclonal antibodies from host veterinary 
species. This creates exciting new opportunities for new pathogen and species reagents, 
exploiting the variable properties antibodies from different species can offer, that can also be 
engineered to have altered functions in different host species.
There are conserved molecular structures, biochemical processes and functional pathways 
between humans, biomedical species, companion animals and veterinary species that enable the 
use of established in vitro/in vivo/in ovo model systems. However, differences between species 
may restrict the interpretation of the outcomes of such model systems. Understanding the 
individual species and comparative responses becomes particularly important when pathogens 
emerge. Studying the immune responses of these species and taking a One Health approach 
more generally (http://www.onehealthglobal.net/) can provide solutions to health problems that 
originate at the animal-human-ecosystems interface18. The success of such approaches 
inevitably depends on the availability of well characterised reagents and established/readily 
accessible experimental methods across multiple species.  The UK Immunological Toolbox 
project is part of this initiative working with partners across the globe. We hope that veterinary 
immunologists and clinicians alike use and engage with this resource to accelerate their own 
research, as well as benefitting others by providing information.
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
Acknowledgements. 
Many thanks to all those that have contributed to the immunological toolbox project to date, 
including attendees at several strategic workshops, those supplying reagent information and 
constructive feedback on the website.   GE received funding from SG RESAS Strategic Research 
Programme, UKRI-BBSRC/SG/BioRad (BB/I019863/1) and European Union Horizon 2020 
(731014). JCH received funding from UKRI-BBSRC (BBS/E/D/20002174; BB/P013740/1; 
BB/I020519/1 and Core Capability Grant awarded to The Roslin Institute [2017-2022]). JAH 
received funding from UKRI-BBSRC (BBS/OS/GC/000015; BBS/E/I/00007030) and BMGF 
(OPP1215550). JAH, GM and WM received funding from UKRI-BBSRC (BBS/E/I/00007038; 
BBS/E/I/00007039) including support from the Pirbright flow cytometry facility. 
Disclosures
The authors have no competing interests to declare
References
1. Swearengen JR. Choosing the right animal model for infectious disease research. Animal Model 
Exp Med 2018; 1:100-8.
2. Roth JA, Tuggle CK. Livestock models in translational medicine. ILAR J 2015; 56:1-6.
3. Mayer A, Mora T, Rivoire O, Walczak AM. Diversity of immune strategies explained by adaptation 
to pathogen statistics. Proc Natl Acad Sci U S A 2016; 113:8630-5.
4. McDaniel MM, Ganusov VV. Estimating Residence Times of Lymphocytes in Ovine Lymph Nodes. 
Front Immunol 2019; 10:1492.
5. Kaufman J. What chickens would tell you about the evolution of antigen processing and 
presentation. Curr Opin Immunol 2015; 34:35-42.
6. Holzer B, Martini V, Edmans M, Tchilian E. T and B Cell Immune Responses to Influenza Viruses in 
Pigs. Front Immunol 2019; 10:98.
7. Taylor G. Animal models of respiratory syncytial virus infection. Vaccine 2017; 35:469-80.
8. Dow S. A Role for Dogs in Advancing Cancer Immunotherapy Research. Front Immunol 2019; 
10:2935.
9. Borzacchiello G, Roperto F, Nasir L, Campo MS. Human papillomavirus research: do we still need 
animal models? Int J Cancer 2009; 125:739-40.
10. Polejaeva IA, Rutigliano HM, Wells KD. Livestock in biomedical research: history, current status 
and future prospective. Reprod Fertil Dev 2016; 28:112-24.
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
11. Wagar LE, DiFazio RM, Davis MM. Advanced model systems and tools for basic and translational 
human immunology. Genome Med 2018; 10:73.
12. Haverson K, Bailey M, Stokes CR, Simon A, LeFlufy L, Banfield G, et al. Monoclonal antibodies 
raised to human cells--specificity for pig leukocytes. Vet Immunol Immunopathol 2001; 80:175-86.
13. Dawson HD, Sang Y, Lunney JK. Porcine cytokines, chemokines and growth factors: 2019 update. 
Res Vet Sci 2020; 131:266-300.
14. Guzman E, Montoya M. Contributions of Farm Animals to Immunology. Front Vet Sci 2018; 5:307.
15. Zaroff S, Tan G. Hybridoma technology: the preferred method for monoclonal antibody 
generation for in vivo applications. Biotechniques 2019; 67:90-2.
16. Entrican G, Lunney JK. Veterinary Immunology Committee Toolkit Workshop 2010: progress and 
plans. Vet Immunol Immunopathol 2012; 148:197-201.
17. BBSRC. BBSRC Veterinary Vaccinology Strategy 2015-2020. 
https://bbsrc.ukri.org/documents/1506-veterinary-vaccinology-strategy/ 2015.
18. FAO OaW. The Tripartite’s Commitment. https://www.who.int/zoonoses/tripartite_oct2017.pdf, 
2017.
